Omeros Corporation
OMERNASDAQHealthcare● Active
$9.91
+$0.12(+1.24%)
Market Cap$717355569
P/E Ratio—
52W High$17.65
52W Low$2.95
Omeros Corporation (OMER) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OMER · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$0.24
Est. -$0.40 · +40.0%
Revenue
$0.01B
Est. $0.00B · +136.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 4-Quarter EPS Beat Streak
OMER reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.06
Rev. $0.47B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.06
Rev. Est.$0.47B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.27 | — | — | — | $0.01B | — |
| ▲ Q2 FY2026 | May 13, 2026 | -$0.40 | -$0.24 | +40.0% | $0.01B | $0.00B | +136.4% |
| ▲ Q1 FY2026 | Mar 31, 2026 | -$0.55 | $3.14 | +670.9% | — | $0.00B | — |
| ▲ Q4 FY2025 | Nov 13, 2025 | -$0.58 | -$0.19 | +67.2% | — | — | — |
| ▲ Q3 FY2025 | Aug 14, 2025 | -$0.55 | -$0.53 | +3.6% | — | $0.00B | — |
| ▼ Q2 FY2025 | May 15, 2025 | -$0.57 | -$0.65 | -14.0% | — | $0.00B | — |
| ▲ Q1 FY2025 | Mar 31, 2025 | -$0.78 | -$0.63 | +19.2% | $0.00B | — | — |
| ▲ Q4 FY2024 | Nov 13, 2024 | -$0.70 | -$0.64 | +8.6% | — | — | — |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.27
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Beat
EPS Actual
-$0.24
EPS Est.
-$0.40
EPS Surpr.
+40.0%
Revenue
$0.01B
Q1 FY2026
Mar 31, 2026Beat
EPS Actual
$3.14
EPS Est.
-$0.55
EPS Surpr.
+670.9%
Revenue
—
Q4 FY2025
Nov 13, 2025Beat
EPS Actual
-$0.19
EPS Est.
-$0.58
EPS Surpr.
+67.2%
Revenue
—
Q3 FY2025
Aug 14, 2025Beat
EPS Actual
-$0.53
EPS Est.
-$0.55
EPS Surpr.
+3.6%
Revenue
—
Q2 FY2025
May 15, 2025Miss
EPS Actual
-$0.65
EPS Est.
-$0.57
EPS Surpr.
-14.0%
Revenue
—
Q1 FY2025
Mar 31, 2025Beat
EPS Actual
-$0.63
EPS Est.
-$0.78
EPS Surpr.
+19.2%
Revenue
$0.00B
Q4 FY2024
Nov 13, 2024Beat
EPS Actual
-$0.64
EPS Est.
-$0.70
EPS Surpr.
+8.6%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.62 | $1.91 | $2.12 | 1 |
| Q3 FY2028 | $1.60 | $1.88 | $2.09 | 1 |
| Q2 FY2028 | $1.64 | $1.93 | $2.15 | 1 |
| Q1 FY2028 | $1.68 | $1.98 | $2.20 | 1 |
| Q4 FY2027 | $0.89 | $1.05 | $1.17 | 1 |
| Q3 FY2027 | $0.91 | $1.07 | $1.19 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.2B | $0.3B | $0.3B | 1 |
| Q3 FY2028 | $0.2B | $0.3B | $0.3B | 1 |
| Q2 FY2028 | $0.2B | $0.3B | $0.3B | 1 |
| Q1 FY2028 | $0.2B | $0.3B | $0.3B | 1 |
| Q4 FY2027 | $0.1B | $0.2B | $0.2B | 1 |
| Q3 FY2027 | $0.1B | $0.2B | $0.2B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 13, 2026 | +40.0% | $14.76 | $14.38 | -2.57% |
| ▲ Q1 FY2026 | Mar 31, 2026 | +670.9% | $9.81 | $10.56 | +7.65% |
| ▲ Q4 FY2025 | Nov 13, 2025 | +67.2% | $6.89 | $6.28 | -8.85% |
| ▲ Q3 FY2025 | Aug 14, 2025 | +3.6% | $4.27 | $4.12 | -3.51% |
| ▼ Q2 FY2025 | May 15, 2025 | -14.0% | $3.93 | $3.95 | +0.51% |
| ▲ Q1 FY2025 | Mar 31, 2025 | +19.2% | $8.47 | $8.22 | -2.95% |
| ▲ Q4 FY2024 | Nov 13, 2024 | +8.6% | $4.26 | $4.19 | -1.64% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +1.8% | $4.37 | $4.15 | -5.03% |
Q2 FY2026-2.57%
Report Date
May 13, 2026
EPS Beat/Miss
+40.0%
Price Before
$14.76
Price After
$14.38
Q1 FY2026+7.65%
Report Date
Mar 31, 2026
EPS Beat/Miss
+670.9%
Price Before
$9.81
Price After
$10.56
Q4 FY2025-8.85%
Report Date
Nov 13, 2025
EPS Beat/Miss
+67.2%
Price Before
$6.89
Price After
$6.28
Q3 FY2025-3.51%
Report Date
Aug 14, 2025
EPS Beat/Miss
+3.6%
Price Before
$4.27
Price After
$4.12
Q2 FY2025+0.51%
Report Date
May 15, 2025
EPS Beat/Miss
-14.0%
Price Before
$3.93
Price After
$3.95
Q1 FY2025-2.95%
Report Date
Mar 31, 2025
EPS Beat/Miss
+19.2%
Price Before
$8.47
Price After
$8.22
Q4 FY2024-1.64%
Report Date
Nov 13, 2024
EPS Beat/Miss
+8.6%
Price Before
$4.26
Price After
$4.19
Q3 FY2024-5.03%
Report Date
Aug 7, 2024
EPS Beat/Miss
+1.8%
Price Before
$4.37
Price After
$4.15
Avg Beat Reaction-2.41%
Avg Miss Reaction+0.51%
Beat Rate7 / 8 quarters
Largest Move-8.85% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OMER ends December
Omeros Corporation (OMER) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-0.24 — beating the analyst consensus of $-0.40 by +40.0%. OMER has beaten EPS estimates for 4 consecutive quarters. The next OMER earnings date is expected around September 1, 2026.
Each quarter, investors track OMER earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OMER revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OMER's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OMER earnings · 5 questionsOmeros Corporation's next earnings report is expected around September 1, 2026. OMER typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OMER historically reports after market close (AMC).
OMER earnings datewhen is OMER earningsOMER next earnings datewhen does OMER report earningsOMER earnings calendar
▸ Source: FMP · Omeros Corporation SEC filings · US GAAP · Omeros Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026